Lymph Nodes Evaluation in Rectal Cancer: Where Do We Stand and Future Perspective
Alessandra Borgheresi1, Federica De Muzio2, Andrea Agostini1,3,4
1Department of Clinical, Special and Dental Sciences, University Politecnica delle Marche, 60121 Ancona, Italy.
Journal of Clinical Medicine
|May 14, 2022
Summary
Assessing lymph node involvement in rectal cancer (RC) is crucial. Advanced MRI techniques and PET/CT offer improved staging but require further validation, impacting treatment decisions.
Area of Science:
- Oncology
- Radiology
- Medical Imaging
Background:
- Nodal involvement assessment is critical for rectal cancer (RC) management.
- Current morphological criteria in MRI for nodal staging have limitations in sensitivity and specificity.
- Existing imaging modalities necessitate further validation for accurate lymph node evaluation in RC.
Purpose of the Study:
- To review current and emerging imaging techniques for assessing lymph node (LN) involvement in RC.
- To discuss the advantages and limitations of various advanced imaging modalities.
- To compare international guidelines for LN evaluation in RC.
Main Methods:
- Narrative review of established and experimental imaging techniques.
- Inclusion of advanced MRI sequences (DWI, IVIM, DKI, DCE) and PET/CT, PET/MRI.
- Discussion of experimental methods like SPIO and DECT, and radiomics analysis.
Main Results:
- Standard MRI criteria for nodal assessment in RC show limitations.
- Advanced MRI techniques and PET-based imaging show promise but need validation.
- Radiomics and novel techniques are emerging areas for LN assessment in RC.
Conclusions:
- Accurate lymph node staging in rectal cancer remains a challenge.
- Advanced imaging techniques show potential to improve diagnostic accuracy over conventional methods.
- Further research and validation are needed for widespread clinical adoption of novel techniques and adherence to guidelines.


